With Expert’Biome™, Lallemand Health Solutions aims to support partners in their development of next-generation strains by offering comprehensive services in the health industry. These services include strains research and development, bioprocesses scaling, drug manufacturing, and other production steps.
By addressing critical challenges in drug manufacturing for health supplements and live biotherapeutics markets, they stand out as a key player in the field. Their manufacturing facilities adhere to the highest quality standards, including Pharmaceutical Good Manufacturing Practices (GMP Pharma). With the launch of Expert’Biome™ CDMO, Lallemand leverages its extensive know-how to support partners in developing next-generation strains.
Want to find out more about EXPERT’Biome CDMO services?
Watch this joint presentation by Laurie Ray, Head of EXPERT’Biome and Sylvie Binda, VP R&D at the past Microbiome Times Partnering Forum in Brussels where they present their turn-key services that cover research and development, commercial production, and regulatory support, drawing on Lallemand’s 90 years of experience in bacterial strain production.